These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35932935)

  • 21. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
    Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
    ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.
    van Steenoven I; van der Flier WM; Scheltens P; Teunissen CE; Lemstra AW
    Alzheimers Res Ther; 2019 Oct; 11(1):83. PubMed ID: 31601267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Challenge of Antidepressant Therapeutics in Alzheimer's Disease.
    Lozupone M; La Montagna M; D'Urso F; Piccininni C; Rinaldi A; Beghi M; Cornaggia CM; Sardone R; Solfrizzi V; Daniele A; Seripa D; Giannelli G; Bellomo A; Panza F
    Adv Exp Med Biol; 2020; 1260():267-281. PubMed ID: 32304037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.
    Chung JK; Plitman E; Nakajima S; Chakravarty MM; Caravaggio F; Gerretsen P; Iwata Y; Graff-Guerrero A;
    J Geriatr Psychiatry Neurol; 2016 May; 29(3):149-59. PubMed ID: 26400248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
    Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
    Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP.
    Sano Y; Nakaya T; Pedrini S; Takeda S; Iijima-Ando K; Iijima K; Mathews PM; Itohara S; Gandy S; Suzuki T
    PLoS One; 2006 Dec; 1(1):e51. PubMed ID: 17183681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum amyloid beta protein in young and elderly depression: a pilot study.
    Kita Y; Baba H; Maeshima H; Nakano Y; Suzuki T; Arai H
    Psychogeriatrics; 2009 Dec; 9(4):180-5. PubMed ID: 20377819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased clearance of CNS beta-amyloid in Alzheimer's disease.
    Mawuenyega KG; Sigurdson W; Ovod V; Munsell L; Kasten T; Morris JC; Yarasheski KE; Bateman RJ
    Science; 2010 Dec; 330(6012):1774. PubMed ID: 21148344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The amyloid hypothesis of Alzheimer's disease at 25 years.
    Selkoe DJ; Hardy J
    EMBO Mol Med; 2016 Jun; 8(6):595-608. PubMed ID: 27025652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain.
    Hey JA; Kocis P; Hort J; Abushakra S; Power A; Vyhnálek M; Yu JY; Tolar M
    CNS Drugs; 2018 Sep; 32(9):849-861. PubMed ID: 30076539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.
    Thal DR; Schultz C; Dehghani F; Yamaguchi H; Braak H; Braak E
    Acta Neuropathol; 2000 Dec; 100(6):608-17. PubMed ID: 11078212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals.
    Kim SH; Fraser PE; Westaway D; St George-Hyslop PH; Ehrlich ME; Gandy S
    J Neurosci; 2010 Mar; 30(11):3870-5. PubMed ID: 20237257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of depression as a risk factor in the development of Alzheimer's disease: the function of AQP4 and the glymphatic system.
    Xia M; Yang L; Sun G; Qi S; Li B
    Psychopharmacology (Berl); 2017 Feb; 234(3):365-379. PubMed ID: 27837334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels.
    Lee M; Guo JP; Kennedy K; McGeer EG; McGeer PL
    J Alzheimers Dis; 2017; 55(3):1175-1182. PubMed ID: 27792013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.